Bachem, a Swiss Speciality cGMP-Manufacturer: History and Future Prospects

Abstract

This article summarizes the development of the Bachem Group and the ongoing commitment regarding its production facilities in Switzerland. Bachem's core business, the manufacture of peptides from lab scale to market quantities, is explained using showcases to detail the high level of know-how needed to successfully prepare very large biomolecules. Based on these examples, the complexity regarding production processes and allocation of manufacturing sites are elucidated.